Filing Details
- Accession Number:
- 0001209191-15-016520
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-20 12:47:21
- Reporting Period:
- 2015-02-18
- Filing Date:
- 2015-02-20
- Accepted Time:
- 2015-02-20 12:47:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1183765 | Threshold Pharmaceuticals Inc | THLD | Pharmaceutical Preparations (2834) | 943409596 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190474 | E Wilfred Jaeger | 3200 Alpine Rd C/O Three Arch Partners Portola Valley CA 94028 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-18 | 25,000 | $3.75 | 80,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrant (Right to Buy) | Acquisiton | 2015-02-18 | 25,000 | $0.00 | 25,000 | $10.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2015-08-18 | 2020-02-18 | No | 4 | P | Direct |
Footnotes
- The reported securities were purchased by the Reporting Person in combination. The purchase price for the shares of common stock and accompanying warrants to purchase common stock was $3.745 for each share of common stock and an accompanying warrant to purchase one share of common stock.
- The exercise price of the warrants is initially $10.86 per share and is subject to certain adjustments as provided in the warrants, provided that in no event will the exercise price per share exceed $10.86 or be below $3.62.